APA (7th ed.) Citation

I, M. J., N, S., N, I., M, P., V, K., T, B. N., & S, V. (2025). Systemic inhibition of bone morphogenetic protein 1.3 as a possible treatment for laminin-related congenital muscular dystrophy. International orthopaedics, 49(1), 45. https://doi.org/10.1007/s00264-024-06389-w

Chicago Style (17th ed.) Citation

I, Matic Jelic, Stokovic N, Ivanjko N, Pecina M, Kufner V, Bordukalo Niksic T, and Vukicevic S. "Systemic Inhibition of Bone Morphogenetic Protein 1.3 as a Possible Treatment for Laminin-related Congenital Muscular Dystrophy." International Orthopaedics 49, no. 1 (2025): 45. https://doi.org/10.1007/s00264-024-06389-w.

MLA (9th ed.) Citation

I, Matic Jelic, et al. "Systemic Inhibition of Bone Morphogenetic Protein 1.3 as a Possible Treatment for Laminin-related Congenital Muscular Dystrophy." International Orthopaedics, vol. 49, no. 1, 2025, p. 45, https://doi.org/10.1007/s00264-024-06389-w.